Back to search

Article

Direct Comparisons of Efficacy and Safety Between Actinomycin-D and Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-Analysis

2021-02-08

Abstract excerpt

<h4>Background: </h4> Actinomycin-D (Act-D) and Methotrexate (MTX) are both effective first-line agents for low-risk gestational trophoblastic neoplasia (LRGTN) with no consensus regarding which is more effective or less toxic. The primary objective of this meta-analysis is to compare Act-D with MTX in the treatment of LRGTN. <h4>Methods: </h4>: We systematically searched electronic databases, conferences abstract...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8fb829bd-5458-5b8c-91bc-433a43ff6260
DOI
10.21203/rs.3.rs-151497/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Direct Comparisons of Efficacy and Safety Between Actinomycin-D and Methotrexate in Women With Low-Risk Gestational Trophoblastic Neoplasia: A Systematic Review and Meta-AnalysisDOI 10.21203/rs.3.rs-151497/v1
Select a neighboring publication to make it the new centre.